Abstract
Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
Jean Higashida, Ted Wun, Sara Schmidt, Stanley M Naguwa and Joseph M Tuscano
The Journal of Rheumatology November 2005, 32 (11) 2109-2115;
Jean Higashida
Ted Wun
Sara Schmidt
Stanley M Naguwa
In this issue
The Journal of Rheumatology
Vol. 32, Issue 11
1 Nov 2005
Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
Jean Higashida, Ted Wun, Sara Schmidt, Stanley M Naguwa, Joseph M Tuscano
The Journal of Rheumatology Nov 2005, 32 (11) 2109-2115;
Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
Jean Higashida, Ted Wun, Sara Schmidt, Stanley M Naguwa, Joseph M Tuscano
The Journal of Rheumatology Nov 2005, 32 (11) 2109-2115;